Author

Brian Koffman

Observed names: DR. Brian Koffman, Dr. Brian Koffman

ORCID: 0000-0001-8829-8283

Observed ORCID: 0000-0001-8829-8283

OpenAlex ID: A5000728753

Management of CLL patients early in the COVID ‐19 pandemic: An international survey of CLL experts

2020 · Brian Koffman, Anthony Mato, et al. · American Journal of Hematology · 20

PDF

Patient preferences for chronic lymphocytic leukemia treatments: a discrete-choice experiment

2024 · Arliene Ravelo, Kelley Myers, et al. · Future Oncology · 13

PDF

Understanding Patient Preferences for Chronic Lymphocytic Leukemia Treatments

2022 · Arliene Ravelo, Kelley Myers, et al. · Blood · 5

Patient Preferences for Fixed Versus Treat-to-Progression Therapies in Chronic Lymphocytic Leukemia

2023 · Arliene Ravelo, Kelley Myers, et al. · Blood · 4

Factors That Influence Treatment Decision-Making: Perspectives of 1147 Chronic Lymphocytic Leukemia (CLL) Patients in the United States

2018 · Brian Koffman, Betsy Dennison, et al. · Blood · 4

Not so crystal clear: observations from a case of crystalline arthritis with cytokine release syndrome (CRS) after chimeric antigen receptor (CAR)-T cell therapy

2018 · Sarah H. Chung, Grant Hughes, et al. · Bone Marrow Transplantation · 4

The 21st century revolution in CLL: Why this matters to patients

2016 · Brian Koffman, Andrew Schorr · Best Practice & Research Clinical Haematology · 3

A charter for improving care for people living with chronic lymphocytic leukemia: six principles for excellence

2025 · Brian Koffman, Lorna Warwick, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2

PDF

Awareness, Knowledge, and Preferences of United States (US) Patients with Chronic Lymphocytic Leukemia (CLL) and Their Caregivers Related to Finite Duration (FD) Therapy and Minimal (Measurable) Residual Disease (MRD)

2021 · Dr. Brian Koffman, Chris Stewart, et al. · Blood · 2

Factors That Influence Patient Treatment Decision Making in the Era of Novel Agents: An Internet-Based Survey of 281 Patients with CLL

2016 · Brian Koffman, Betsy Dennison, et al. · Blood · 2

Feasibility of Bruton’s Tyrosine Kinase Inhibitor Discontinuation in Chronic Lymphocytic Leukemia: The Patient Perspective

2025 · Deborah M. Stephens, Chris Stewart, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

Feasibility of Discontinuation of Bruton's Tyrosine Kinase Inhibitors in Patients with Chronic Lymphocytic Leukemia: A Patient Survey

2024 · Deborah M. Stephens, Chris Stewart, et al. · Blood · 1

Improving Physician-Patient Decision Making for Treatment of Chronic Lymphocytic Leukemia with BTK Inhibition

2020 · Tariqa A Ackbarali, Matthew S. Davids, et al. · Blood · 1

An Innovative Telemedicine Platform to Provide Expert Access to Patients with Chronic Lymphocytic Leukemia (CLL)

2019 · DR. Brian Koffman, John M. Pagel, et al. · Blood · 1

A U.S.-based survey: The experiences of 1147 chronic lymphocytic leukemia (CLL) patients (pts).

2018 · Brian Koffman, Betsy Dennison, et al. · Journal of Clinical Oncology · 1

Use of CME to impact self-reported changes in the evaluation and management of anaemia in geriatric patients

2015 · Kathleen Farmer, Betsy Dennison, et al. · Journal of European CME · 1

PDF

Treatment Decision-Making for Individuals with Relapsed/Refractory Chronic Lymphocytic Leukemia in the USA

2026 · Catherine C. Coombs, Thomas W. LeBlanc, et al. · Acta Haematologica

Integrating patient and clinician perspectives to advance R/R CLL care: Results of a multi-pronged global initiative

2025 · Carmine Deluca, Michael Beyer, et al. · Blood

Optimizing adherence to oral CLL therapies in community oncology centers: Key findings from a quality improvement initiative

2025 · Javier Pinilla-Ibarz, Brian Koffman, et al. · Blood

Impact of testing for genetic markers on treatment selection and clinical outcomes among patients with chronic lymphocytic leukemia

2025 · Brian Koffman, Xiaoliang Wang, et al. · Blood

PDF

Real-world (RW) use of fixed-duration (FD) ibrutinib+venetoclax (Ibr+Ven) in patients (pts) with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Pooled analysis of REALITY-worldwide (WW) and REALITY-2 prospective cohort studies

2025 · Catherine Thieblemont, Emmanuelle Tchernonog, et al. · Blood

PDF

The Value of Collaboration with Patient Advocacy Organizations to Enhance Initiatives Focused on Patient-Centered Care and Improve Outcomes in Chronic Lymphocytic Leukemia

2023 · Carmine Deluca, Michael Beyer, et al. · Blood

Global Perspectives of Lived Experience with CLL - Patient and Support Group Reported Insights of Access, Treatment, and Unmet Needs

2023 · Kathryn Huntley, Brian Koffman, et al. · Blood

Pb1936: Identifying Inequities in Support - Global Survey of Patient Organisations Delivering Support Services for Cll Patients

2023 · Deborah Baker, Nick York, et al. · HemaSphere

Utility of an Online CLL Treatment Decision Support Tool As a Resource for Patients and Caregivers

2020 · Ryan P Topping, Timothy A Quill, et al. · Blood

Works count: 27

Citation count: 65

H-index: 4

I10-index: 2